Skip to main content
Erschienen in: Heart and Vessels 4/2023

09.11.2022 | Original Article

Improvement of physical activity significantly reduced serum hepatocyte growth factor levels in a general population: 10 year prospective study

verfasst von: Akiko Sakaue, Hisashi Adachi, Mika Enomoto, Ako Fukami, Yume Nohara, Nagisa Morikawa, Maki Yamamoto, Hiromi Sato, Kenta Murotani, Yoshihiro Fukumoto

Erschienen in: Heart and Vessels | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Hepatocyte growth factor (HGF) is an adipocytokine elevated in obese subjects. We have previously reported that serum HGF levels were significantly associated with insulin resistance or components of the metabolic syndrome. However, it has been unknown how physical activity (PA) affects HGF levels after a long-term follow-up. Our aim was to clarify the association between PA changes and HGF levels as well as cerebro-cardiovascular disease (CVD) development, during a 10 year follow-up period in a Japanese general population. Of 1320 subjects who received a health check-up examination in Tanushimaru town in 1999, 903 subjects (341 males and 562 females), who received the examination both in 1999 and 2009 were enrolled. We evaluated their PA levels by Baecke questionnaire in 1999 and by a simple questionnaire in 2009. We measured the HGF levels by ELISA method in 1999 and 2009. We divided the subjects into four PA groups, stable low PA, increased PA, decreased PA, and stable high PA. Using these questionnaires, we compared their PA and HGF levels after an interval of 10 years. A significant inverse association was found between PA changes and HGF levels at 10 years, after adjustment for age and sex. The HGF levels of the increased PA group were significantly lower than stable low PA (p = 0.038), and the increased PA group showed reduced CVD development compared to the stable low PA group after adjustment for age and sex (p = 0.012). Our data demonstrated that improvement of PA levels was associated with reduced HGF levels and CVD development.
Literatur
1.
Zurück zum Zitat Nakamura T, Nawa K, Ichihara A (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122:1450–1459CrossRefPubMed Nakamura T, Nawa K, Ichihara A (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122:1450–1459CrossRefPubMed
2.
Zurück zum Zitat Nakamura T, Teramoto H, Ichihara A (1986) Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 83:6489–6493CrossRefPubMedPubMedCentral Nakamura T, Teramoto H, Ichihara A (1986) Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 83:6489–6493CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Hiratsuka A, Adachi H, Fujiura Y, Yamagishi S, Hirai Y, Enomoto M, Satoh A, Hino A, Furuki K, Imaizumi T (2005) Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab 90:2927–2931CrossRefPubMed Hiratsuka A, Adachi H, Fujiura Y, Yamagishi S, Hirai Y, Enomoto M, Satoh A, Hino A, Furuki K, Imaizumi T (2005) Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab 90:2927–2931CrossRefPubMed
4.
Zurück zum Zitat Tsukagawa E, Adachi H, Hirai Y, Enomoto M, Fukami A, Ogata K, Kasahara A, Yokoi K, Imaizumi T (2013) Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10 year prospective study. Clin Endocrinol 79:43–48CrossRef Tsukagawa E, Adachi H, Hirai Y, Enomoto M, Fukami A, Ogata K, Kasahara A, Yokoi K, Imaizumi T (2013) Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10 year prospective study. Clin Endocrinol 79:43–48CrossRef
5.
Zurück zum Zitat Haufe S, Kerling A, Protte G, Bayerle P, Stenner HT, Rolff S, Sundermeier T, Kück M, Ensslen R, Nachbar L, Lauenstein D, Böthig D, Bara C, Hanke AA, Terkamp C, Stiesch M, Hilfiker-Kleiner D, Haverich A, Tegtbur U (2019) Telemonitoring-supported exercise training, metabolic syndrome severity, and work ability in company employees: a randomized controlled trial. Lancet Public Health 4:e343-352CrossRefPubMed Haufe S, Kerling A, Protte G, Bayerle P, Stenner HT, Rolff S, Sundermeier T, Kück M, Ensslen R, Nachbar L, Lauenstein D, Böthig D, Bara C, Hanke AA, Terkamp C, Stiesch M, Hilfiker-Kleiner D, Haverich A, Tegtbur U (2019) Telemonitoring-supported exercise training, metabolic syndrome severity, and work ability in company employees: a randomized controlled trial. Lancet Public Health 4:e343-352CrossRefPubMed
7.
Zurück zum Zitat Roberts CK, Hevener AL, Barnard RJ (2013) Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compre Physiol 3:1–58 Roberts CK, Hevener AL, Barnard RJ (2013) Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compre Physiol 3:1–58
8.
Zurück zum Zitat Henriksen EJ (2002) Invited review: effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 93:788–796CrossRefPubMed Henriksen EJ (2002) Invited review: effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 93:788–796CrossRefPubMed
9.
Zurück zum Zitat Adachi H, Hirai Y, Sasaki S, Enomoto M, Fukami A, Kumagai E, Esaki E, Imaizumi T (2011) Trends in dietary intakes and serum cholesterol levels over 50 years in tanushimaru in Japanese men. Food Nutr Sci 2:476–481 Adachi H, Hirai Y, Sasaki S, Enomoto M, Fukami A, Kumagai E, Esaki E, Imaizumi T (2011) Trends in dietary intakes and serum cholesterol levels over 50 years in tanushimaru in Japanese men. Food Nutr Sci 2:476–481
10.
Zurück zum Zitat Hino A, Adachi H, Toyomasu K, Yoshida N, Enomoto M, Hiratsuka A, Hirai Y, Satoh A, Imaizumi T (2004) Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 176:145–149CrossRefPubMed Hino A, Adachi H, Toyomasu K, Yoshida N, Enomoto M, Hiratsuka A, Hirai Y, Satoh A, Imaizumi T (2004) Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 176:145–149CrossRefPubMed
11.
Zurück zum Zitat Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942CrossRefPubMed Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942CrossRefPubMed
12.
Zurück zum Zitat Sakaue A, Adachi H, Enomoto M, Fukami A, Kumagai E, Nakamura S, Nohara Y, Kono S, Nakao E, Morikawa N, Tsuru T, Hamamura H, Yoshida N, Fukumoto Y (2020) Association between physical activity, occupational sitting time and mortality in a general population: An 18 year prospective survey in Tanushimaru, Japan. Eur J Prev Cardiol 27:758–766CrossRefPubMed Sakaue A, Adachi H, Enomoto M, Fukami A, Kumagai E, Nakamura S, Nohara Y, Kono S, Nakao E, Morikawa N, Tsuru T, Hamamura H, Yoshida N, Fukumoto Y (2020) Association between physical activity, occupational sitting time and mortality in a general population: An 18 year prospective survey in Tanushimaru, Japan. Eur J Prev Cardiol 27:758–766CrossRefPubMed
13.
Zurück zum Zitat Oyeyemi AL, Moss SJ, Monyeki MA, Kruger HS (2016) Measurement of physical activity in urban and rural South African adults: a comparison of two self-report methods. BMC Public Health 16:1004CrossRefPubMedPubMedCentral Oyeyemi AL, Moss SJ, Monyeki MA, Kruger HS (2016) Measurement of physical activity in urban and rural South African adults: a comparison of two self-report methods. BMC Public Health 16:1004CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y, Nakamura T (1995) Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res 16:105–114CrossRef Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y, Nakamura T (1995) Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res 16:105–114CrossRef
15.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
16.
Zurück zum Zitat Ura N, Saitoh S, Shimamoto K (2007) Clinical diagnosis of metabolic syndrome 1: metabolic syndrome and insulin resistance. Intern Med 46:1283–1284CrossRefPubMed Ura N, Saitoh S, Shimamoto K (2007) Clinical diagnosis of metabolic syndrome 1: metabolic syndrome and insulin resistance. Intern Med 46:1283–1284CrossRefPubMed
17.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed
18.
Zurück zum Zitat Florido R, Kwak L, Lazo M, Nambi V, Ahmed HM, Hegde SM, Gerstenblith G, Blumenthal RS, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE (2018) Six-year changes in physical activity and the risk of incident heart failure: aric study. Circulation 137:2142–2151CrossRefPubMedPubMedCentral Florido R, Kwak L, Lazo M, Nambi V, Ahmed HM, Hegde SM, Gerstenblith G, Blumenthal RS, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE (2018) Six-year changes in physical activity and the risk of incident heart failure: aric study. Circulation 137:2142–2151CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Decker PA, Larson NB, Bell EJ, Pankow JS, Hanson NQ, Wassel CL, Tsai MY, Bielinski SJ (2019) Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the multi-ethnic study of atherosclerosis (MESA). Am Heart J 213:30–34CrossRefPubMedPubMedCentral Decker PA, Larson NB, Bell EJ, Pankow JS, Hanson NQ, Wassel CL, Tsai MY, Bielinski SJ (2019) Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the multi-ethnic study of atherosclerosis (MESA). Am Heart J 213:30–34CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Lamblin N, Susen S, Dagorn J, Mouquet F, Jude B, Van Belle E, Bauters C, de Groote P (2005) Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J 150:137–143CrossRefPubMed Lamblin N, Susen S, Dagorn J, Mouquet F, Jude B, Van Belle E, Bauters C, de Groote P (2005) Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J 150:137–143CrossRefPubMed
21.
Zurück zum Zitat Bell EJ, Larson NB, Decker PA, Pankow JS, Tsai MY, Hanson NQ, Wassel CL, Longstreth WT Jr, Bielinski SJ (2016) Hepatocyte growth factor is positively associated with risk of stroke: the MESA (multi-ethnic study of atherosclerosis). Stroke 47:2689–2694CrossRefPubMedPubMedCentral Bell EJ, Larson NB, Decker PA, Pankow JS, Tsai MY, Hanson NQ, Wassel CL, Longstreth WT Jr, Bielinski SJ (2016) Hepatocyte growth factor is positively associated with risk of stroke: the MESA (multi-ethnic study of atherosclerosis). Stroke 47:2689–2694CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Bell EJ, Decker PA, Tsai MY, Pankow JS, Hanson NQ, Wassel CL, Larson NB, Cohoon KP, Budoff MJ, Polak JF, Stein JH, Bielinski SJ (2018) Hepatocyte growth factor is associated with progression of atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 272:162–167CrossRefPubMedPubMedCentral Bell EJ, Decker PA, Tsai MY, Pankow JS, Hanson NQ, Wassel CL, Larson NB, Cohoon KP, Budoff MJ, Polak JF, Stein JH, Bielinski SJ (2018) Hepatocyte growth factor is associated with progression of atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 272:162–167CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Osibogun O, Ogunmoroti O, Ferraro RA, Ndumele CE, Burke GL, Larson NB, Bielinski SJ, Michos ED (2022) Favorable cardiovascular health is associated with lower hepatocyte growth factor levels in the multi-ethnic study of atherosclerosis. Front Cardiovasc Med 8:760281CrossRefPubMedPubMedCentral Osibogun O, Ogunmoroti O, Ferraro RA, Ndumele CE, Burke GL, Larson NB, Bielinski SJ, Michos ED (2022) Favorable cardiovascular health is associated with lower hepatocyte growth factor levels in the multi-ethnic study of atherosclerosis. Front Cardiovasc Med 8:760281CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA (1991) Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 88:904–910CrossRefPubMedPubMedCentral Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA (1991) Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 88:904–910CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L (1992) Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 90:1582–1592CrossRefPubMedPubMedCentral Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L (1992) Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 90:1582–1592CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Nakano N, Morishita R, Moriguchi A, Nakamura Y, Hayashi SI, Aoki M, Kida I, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1998) Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease. Hypertension 32:444–451CrossRefPubMed Nakano N, Morishita R, Moriguchi A, Nakamura Y, Hayashi SI, Aoki M, Kida I, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1998) Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease. Hypertension 32:444–451CrossRefPubMed
27.
Zurück zum Zitat Florido R, Zhao DI, Ndumele CE, Bluemke DA, Heckbert SR, Allison MA, Ambale-Venkatesh B, Liu CY, Lima J, Michos ED (2019) Change in physical activity and cardiac structure over 10 years: the multi-ethnic study of atherosclerosis. Med Sci Sports Exerc 51:2033–2040CrossRefPubMedPubMedCentral Florido R, Zhao DI, Ndumele CE, Bluemke DA, Heckbert SR, Allison MA, Ambale-Venkatesh B, Liu CY, Lima J, Michos ED (2019) Change in physical activity and cardiac structure over 10 years: the multi-ethnic study of atherosclerosis. Med Sci Sports Exerc 51:2033–2040CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Castro-Diehl C, Song RJ, Sawyer DB, Wollert KC, Mitchell GF, Cheng S, Vasan RS, Xanthakis V (2021) Circulating growth factors and cardiac remodeling in the community: the Framingham heart study. Int J Cardiol 329:217–224CrossRefPubMedPubMedCentral Castro-Diehl C, Song RJ, Sawyer DB, Wollert KC, Mitchell GF, Cheng S, Vasan RS, Xanthakis V (2021) Circulating growth factors and cardiac remodeling in the community: the Framingham heart study. Int J Cardiol 329:217–224CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Lamblin N, Bauters A, Fertin M, de Groote P, Pinet F, Bauters C (2011) Circulating levels of hepatocyte growth factor and left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Eur J Heart Fail 13:1314–1322CrossRefPubMed Lamblin N, Bauters A, Fertin M, de Groote P, Pinet F, Bauters C (2011) Circulating levels of hepatocyte growth factor and left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Eur J Heart Fail 13:1314–1322CrossRefPubMed
30.
Zurück zum Zitat Kuznetsova T, Haddad F, Knez J, Rosenberg-Hasson Y, Sung J, Cauwenberghs N, Thijs L, Karakikes I, Maecker H, Mahaffey KW, Wu JC, Staessen JA (2015) Cytokines profile in hypertensive patients with left ventricular remodeling and dysfunction. J Am Soc Hypertens 9:975–984CrossRefPubMed Kuznetsova T, Haddad F, Knez J, Rosenberg-Hasson Y, Sung J, Cauwenberghs N, Thijs L, Karakikes I, Maecker H, Mahaffey KW, Wu JC, Staessen JA (2015) Cytokines profile in hypertensive patients with left ventricular remodeling and dysfunction. J Am Soc Hypertens 9:975–984CrossRefPubMed
Metadaten
Titel
Improvement of physical activity significantly reduced serum hepatocyte growth factor levels in a general population: 10 year prospective study
verfasst von
Akiko Sakaue
Hisashi Adachi
Mika Enomoto
Ako Fukami
Yume Nohara
Nagisa Morikawa
Maki Yamamoto
Hiromi Sato
Kenta Murotani
Yoshihiro Fukumoto
Publikationsdatum
09.11.2022
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 4/2023
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02198-6

Weitere Artikel der Ausgabe 4/2023

Heart and Vessels 4/2023 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.